stars 1 stars 2 stars 3

View Cassava Sciences, Inc.'s top competitors like Alzheon, Inc. | Preserving Future Memories, Anavex Life Sciences, and Axovant Sciences Ltd.

Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life is more than just a destination. We’re concerned with the journey, and we care deeply about everyone contributing to and benefiting from our own company journey. This means helping people discover the right path for them and carefully guiding colleagues along the way. Read our Community Guidelines: http://bit.ly/2tFyAoj
Cambridge, Massachusetts, US
Public
$6.5M Revenue
http://www.sagerx.com
181 Employees
SAGE Ticker
Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. Biohaven obtained licenses from Yale University School of Medicine and Massachusetts General Hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders. The mission of the company is to exploit advances over the past decade in the understanding of glutamate mechanisms involved in a variety of diseases. The company’s first drug candidate is being developed for orphan neurological disorders as well as treatment-resistant anxiety and depression. Biohaven has assembled a team of experts who have extensive experience in the development of therapeutic agents in this area and also comprise the originators at Yale University who discovered the therapeutic potential of glutamate modulation in anxiety and depression. Team members have designed and executed successful development programs testing a variety of agents in affective disorders, leading to first-cycle FDA approvals and successful commercialization.
New Haven, Connecticut, US
Public
$155.6M Revenue
http://www.biohavenpharma.com
36 Employees
BHVN Ticker
We are a research-based and leading Japanese multinational pharmaceutical company engaged in the marketing and sales of highly ethical products. We have built a strong reputation in the local pharma scene over the years through the efficacy of our products backed by clinical studies and research.We are inspired by a global commitment to the development of innovative healthcare products. Our partnership with the medical community is founded on a shared vision to continuously improve patients’ quality of life. Moreover, we take pride that our company offers patient care programs that benefit both patient and family, providing better access to information and disease management. For more information about our company, please visit our website at: www.otsuka.com.ph
PH
Private
$15B Revenue
https://www.otsuka.com
68 Employees

Top Cassava Sciences, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users